Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Unknown 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 28NSCLC 4Brain Neoplasms 4Lung Neoplasms 3Pancreatic Neoplasms 2EGF-R Positive Non-Small Cell Lung Cancer 2Adenocarcinoma 2Squamous Cell Carcinoma of Lung 1Plasma EGFR Mutation-positive Lung Cancer 1Non-squamous Non-small Cell Lung Cancer 1Non-Small-Cell Lung 1Neoplasms, Second Primary 1Nasopharyngeal Carcinoma 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Adenocarcinoma of Lung 1

Interventions

Gefitinib 5icotinib 4Pemetrexed 4Docetaxel 4camrelizumab 3apatinib 3anlotinib 3aflutinib 3Erlotinib Hydrochloride 3osimertinib 2dacomitinib 2Thalidomide 2Radiosurgery 2Drug Therapy 2Carboplatin 2Afatinib 2trilaciclib 1spartalizumab 1pembrolizumab 1nimotuzumab 1famitinib 1envafolimab 1Vinorelbine 1Tyrosine Kinase Inhibitors 1S 1 (combination) 1Radiofrequency Ablation 1Microphysiological Systems 1Immune Checkpoint Inhibitors 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × NSCLC × icotinib × Clear all
NCT04575415 2020-10-20

BELLA

Guangdong Association of Clinical Trials

Unknown
272 enrolled
Thoracic

NSCLC

NCT02404675 2017-07-28

INCREASE

Betta Pharmaceuticals Co., Ltd.

Phase 4 Unknown
240 enrolled
Thoracic

NSCLC

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Henan Provincial People's Hospital

Phase 4 Unknown
67 enrolled
Thoracic

NSCLC

NCT02272127 2014-10-22

Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer

Nanfang Hospital, Southern Medical University

Phase 2 Unknown
100 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡